Brightgene Bio-medical Technology Co (SHSE:688166) FCF Yield % : -0.43 (As of Jul. 19, 2025)

View and export this data going back to 2019. Start your Free Trial

What is Brightgene Bio-medical Technology Co FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Brightgene Bio-medical Technology Co's Trailing 12-Month Free Cash Flow is ¥-156 Mil, and Market Cap is ¥36,481 Mil. Therefore, Brightgene Bio-medical Technology Co's FCF Yield % for today is -0.43%.

The historical rank and industry rank for Brightgene Bio-medical Technology Co's FCF Yield % or its related term are showing as below:

SHSE:688166' s FCF Yield % Range Over the Past 10 Years
Min: -9.91 Med: -1.2 Max: -0.07
Current: -0.43

During the past 9 years, the highest FCF Yield % of Brightgene Bio-medical Technology Co was -0.07%. The lowest was -9.91%. And the median was -1.20%.

SHSE:688166's FCF Yield % is ranked better than
82.29% of 1485 companies
in the Biotechnology industry
Industry Median: -12.26 vs SHSE:688166: -0.43

Brightgene Bio-medical Technology Co's FCF Margin % for the quarter that ended in Mar. 2025 was -46.08%.

Brightgene Bio-medical Technology Co FCF Yield % Historical Data

The historical data trend for Brightgene Bio-medical Technology Co's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Brightgene Bio-medical Technology Co FCF Yield % Chart

Brightgene Bio-medical Technology Co Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

FCF Yield %

Get a 7-Day Free Trial

-1.06

-4.87

-4.36

-1.41

-0.09

Brightgene Bio-medical Technology Co Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
FCF Yield %	Get a 7-Day Free Trial															0.96	-1.90	-2.50	3.76	-2.74

Competitive Comparison of Brightgene Bio-medical Technology Co's FCF Yield %

For the Biotechnology subindustry, Brightgene Bio-medical Technology Co's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Brightgene Bio-medical Technology Co's FCF Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Brightgene Bio-medical Technology Co's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Brightgene Bio-medical Technology Co's FCF Yield % falls into.

Save Embed

;

Save Embed

;

Brightgene Bio-medical Technology Co FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Brightgene Bio-medical Technology Co's FCF Yield % for the fiscal year that ended in Dec. 2024 is calculated as

FCF Yield %	=	Free Cash Flow	/	Market Cap
	=	-11.64	/	12758.5034
	=	-0.09%

Brightgene Bio-medical Technology Co's annualized FCF Yield % for the quarter that ended in Mar. 2025 is calculated as

FCF Yield %	=	Free Cash Flow	*	Annualized Factor	/	Market Cap
	=	-114.717	*	4	/	16759.3849
	=	-2.74%

Brightgene Bio-medical Technology Co FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.

Brightgene Bio-medical Technology Co FCF Yield % Related Terms

Thank you for viewing the detailed overview of Brightgene Bio-medical Technology Co's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

Brightgene Bio-medical Technology Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Brightgene Bio-medical Technology Co Ltd (SHSE:688166) » Definitions » FCF Yield %

Comparable Companies

Traded in Other Exchanges

N/A

Address

Xinghu Street, Industrial Park, Building C25-C28, Bio-Nano Park, No. 218, Suzhou, CHN, 215123

Website

http://www.bright-gene.com

Brightgene Bio-medical Technology Co Ltd is a pharmaceutical company engaged in research, development and production of new drugs and high-end generic drugs. The company develops macrolides, peptides, polysaccharides, heterocycles, azoles, azines, phenyl ethers, tetracyclines, and production of non-pharmaceutical macrolides, peptides, polysaccharides, heterocycles, azoles, azines, benzene Ethers, tetracyclines.

Brightgene Bio-medical Technology Co Headlines

No Headlines